These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1469 related articles for article (PubMed ID: 8325997)

  • 1. Syndrome X: what's old, what's new, what's etiologic?
    Ginsberg HN
    J Clin Invest; 1993 Jul; 92(1):3. PubMed ID: 8325997
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin resistance and arterial hypertension].
    Ryder E
    Invest Clin; 1992; 33(1):1-3. PubMed ID: 1391073
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
    Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R
    Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk factors and etiology of retinal vein occlusion].
    Zhioua R; Sebaï L; Kriaa L; el Euch M; Mabrouk S; Ouertani A
    Tunis Med; 1995 Feb; 73(2):133-6. PubMed ID: 9506155
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus.
    Lewis GF; Steiner G
    Diabetes Metab Rev; 1996 Apr; 12(1):37-56. PubMed ID: 8861500
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic syndrome' in a middle-aged Finnish population.
    Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Takala JK
    J Cardiovasc Risk; 1997 Aug; 4(4):291-5. PubMed ID: 9477208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between parameters of hemostasis and manifestations of the metabolic syndrome in men with mild and moderate hypertension].
    Ratnikova LA; Metel'skaia VA; Mamedov MN; Olfer'ev AM; Perova NV
    Ter Arkh; 2000; 72(9):13-6. PubMed ID: 11076408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome: what's in a name?
    Wubben DP; Adams AK
    WMJ; 2006 Jul; 105(5):17-20. PubMed ID: 16933408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertriglyceridemia and arteriosclerosis].
    Hata Y
    Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1795-805. PubMed ID: 1479221
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
    Malloy MJ; Kane JP
    Adv Intern Med; 2001; 47():111-36. PubMed ID: 11795072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance (metabolic) syndrome in children.
    Rosenberg B; Moran A; Sinaiko AR
    Panminerva Med; 2005 Dec; 47(4):229-44. PubMed ID: 16489322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How I investigate...the insulin resistance syndrome using biological markers].
    Luyckx F; Scheen AJ; Gielen J; Lefèbvre PJ
    Rev Med Liege; 1997 Oct; 52(10):686-91. PubMed ID: 9446171
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic risk factors associated with erosive esophagitis.
    Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic and hormonal links in obese individuals with and without symptoms of syndrome X].
    Nedĕlníková K; Svacina S; Matoulek M; Sonka J
    Sb Lek; 2000; 101(1):67-9. PubMed ID: 10953633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance and metabolic syndrome in first-degree relatives of patients with NIDDM].
    Camps I; Biarnés J; Fernández-Real JM; Insa R; Soler J; Fernández Castañer M
    Med Clin (Barc); 1999 Mar; 112(8):281-4. PubMed ID: 10207842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.